X0202 SCHEDULE 13G/A 0001879713-25-000002 0001879713 XXXXXXXX LIVE 1 Class A Common Shares 09/02/2026 0001702123 Cardiol Therapeutics Inc. 14161Y200 602-2265 UPPER MIDDLE ROAD EAST 602-2265 UPPER MIDDLE ROAD EAST OAKVILLE A6 L6H 0G5 Rule 13d-1(b) Tejara Capital Ltd X0 0.00 0.00 0.00 6382551.00 6382551.00 5.3 OO Fund Manager authorised by FCA in UK Cardiol Therapeutics Inc. 602-2265 UPPER MIDDLE ROAD EAST, 602-2265 UPPER MIDDLE ROAD EAST, OAKVILLE, ONTARIO, CANADA, L6H 0G5. i. Trefoil Select Funds SPC-Stylus SP ii. Tejara Capital Limited i. C/O Apex Funds Services Cayman Ltd, 3rd Floor, Citrus Gove Building, 106 Goring Ave, Grand Cayman, George Town KY1-1001, Cayman Islands ii. 4th Floor, 40 Grosvenor Gardens, London SW1W 0EB, United Kingdom i. Cayman ii. United Kingdom N FI Tejara Capital Limited is authorised by FCA in UK as a fund manager and it manages the fund Trefoil Select Funds SPC- Stylus SP, that is registered in Cayman 6,382,551 5.3 0 0 0 6,382,551 Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. By signing below I certify that, to the best of my knowledge and belief, the foreign regulatory scheme applicable to a fund manager authorised and regulated by the FCA in the UK is substantially comparable to the regulatory scheme applicable to the functionally equivalent U.S. institution(s). I also undertake to furnish to the Commission staff, upon request, information that would otherwise be disclosed in a Schedule 13D. Tejara Capital Ltd Miyan Mansur Mannan 09/23/2026